The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4905822 6132108 I 4905822-6 19990722 20050630 20060113 PER HQWYE970405JUL05 WYETH PHARMACEUTICALS INC. F N 20051223 LW UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4905822 1006917211 PS PREMPHASE (PREMARIN;CYCRIN 14/14) 1 ORAL ORAL D D 20527

Indications of drugs used

Event ID DRUG SEQ INDI PT
4905822 1006917211 HORMONE REPLACEMENT THERAPY

Outcome of event

Event ID OUTC COD
4905822 OT

Reactions reported

Event ID PT
4905822 BREAST CANCER

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
4905822 CSM

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
4905822 1006917211 19971101